SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-030867
Filing Date
2022-11-08
Accepted
2022-11-08 06:05:18
Documents
2
Period of Report
2022-08-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 39260
2 ex24-1.htm EX-24.1 11372
  Complete submission text file 0001493152-22-030867.txt   52042
Mailing Address C/O HEALTHWORLD CORP 100 AVENUE OF THE AMERICAS NEW YORK NY 10013
Business Address
GIRGENTI STEVEN (Reporting) CIK: 0001055530 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41463 | Film No.: 221367073

Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Issuer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research